Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Prevention of Peginterferon-induced Psychopathology (POPS)
NCT00133276Phase 3Completed
- Sponsor
- Foundation for Liver Research
- Start
- Aug 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in psychiatric disorder, sponsored by Foundation for Liver Research. Started Aug 2005; status: completed.
02
Drugs
escitalopram
03
Conditions
psychiatric disorder
Beyond the preview
Go deeper on NCT00133276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133276.